The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures
**Background:** Pharmaceutical firms spend billions of dollars developing new therapies, which are often sold at a substantial premium over older therapies. The costs and benefits of these newer and more expensive drugs, however, are controversial. The empirical evidence on whether newer drugs can d...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | http://jheor.scholasticahq.com/article/9873-the-impacts-of-breakthrough-drug-classes-on-total-healthcare-expenditures.pdf |